Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

(

CATNIP

)

ITN Protocol #:

ITN057AD

Branded Name:

CATNIP

ClinicalTrials.Gov ID:

NCT02237196

Treatment Protocol #:

Therapeutic Area:

Allergy & Asthma

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

Rho Scientist

Study Personnel:

Protocol Chair

Jonathan Corren, MD jcorren@ucla.edu

Work:

310-477-1734 Ext. 250

Protocol Chair

Don Whitehouse dwhitehouse@immunetolerance.org

Work:

415-353-4426

Protocol Chair

Don Whitehouse dwhitehouse@immunetolerance.org

Work:

415-353-4426

Protocol Chair

David Larson dlarson@immunetolerance.org

Work:

(240) 235-6159

Protocol Chair

Noha Lim, PhD nlim@immunetolerance.org

Work:

240-235-6151

Protocol Chair

Srinath Sanda, MD ssanda@immunetolerance.org

Work:

415-353-4414

Protocol Chair

Joy Laurienzo JLaurienzo@niaid.nih.gov

Work:

301-451-4415

Protocol Chair

Miguel Villareal

Work:

214-842-8006